Drug Shortage Report for DOCETAXEL INJECTION
| Report ID | 249508 |
| Drug Identification Number | 02439336 |
| Brand name | DOCETAXEL INJECTION |
| Common or Proper name | DOCETAXEL INJECTION |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | DOCETAXEL |
| Strength(s) | 10MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 16ML |
| ATC code | L01CD |
| ATC description | PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS |
| Reason for shortage | Shortage of an active ingredient. |
| Anticipated start date | 2025-02-20 |
| Actual start date | |
| Estimated end date | 2025-04-30 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-02-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | Yes |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-02-06 | English | Compare |
| v3 | 2025-02-03 | French | Compare |
| v2 | 2025-02-03 | English | Compare |
| v1 | 2025-02-03 | English | Compare |
Showing 1 to 4 of 4